Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.
You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Geovax Labs (NASDAQ:GOVX).
Marker Therapeutics has a consensus price target of $6.00.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $2.94 last updated September 20, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.